InvestorsHub Logo
Boards
News
Market Data
Markets
Discover
Discover
Subscribe Login/Register
S&P 500
5,222.68
(
0.16%
)
US TECH 100
17,650.00
(
0.05%
)
Dow Jones
39,512.84
(
0.32%
)
Brent Oil
82.59
(
0.00%
)
Bitcoin
61,178.97
(
0.63%
)
Post# of 2338749
Next 10
Reply Private New
Public Reply Private Reply New Post
Keep Last Read
Keep Next 10 Report Keyboard Shortcuts
Next 10 Prev Next

CashMoneyNY

Send PM Follow Ignore
Followers 24
Posts 2195
Boards Moderated 0
Alias Born 04/26/2012

CashMoneyNY

Re: None

Monday, 04/29/2019 7:28:32 PM

Monday, April 29, 2019 7:28:32 PM

Post# of 2338749
$PULM

Pulmatrix Inc. Pulmazole Deal with Cipla Tachnologies
Binding Term Sheet with Cipla Technologies LLC for the development and commercialization of Pulmazole (PUR1900) for the treatment of allergic bronchopulmonary aspergillosis in asthma patients.
Under the terms of the deal, if formally executed,

PULM will receive $22M upfront and will retain the right to receive 50% of the free cash flow from future Pulmazole sales. PULM will be primarily responsible for clinical development while Cipla will be responsible for commercialization.

Public Reply Private Reply New Post
Keep Last Read
Keep Last Read Next 10 Report Keyboard Shortcuts
Next 10 Prev Next

Join the InvestorsHub Community

Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.

Sign Up